Effective Measurement of Risperidone Treatment Outcome for Persons With Borderline Personality Disorder
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The objective of Study A is to evaluate the efficacy of risperidone on the 4 behavioral
dimensions of Berderline Personality Disorder (BPD)in an open label trial:mood swings,
impulsivity, thing difficulties and disturbed relationships. The secondary objective of this
study (Study B)is to validate a self-report measure of clinical symptoms specific to the
treatment of patients with BPD, the UAB Borderline Rating Scale(BRS).